<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>PENDING</status><version>v2</version><patient-age>51</patient-age><report-id>US-PFIZER INC-2013032670</report-id><gender>female</gender><reactions><reaction>toes had swelled</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>Lyrica</drug-name><manufacturer/><ingredients/></drug></drugs><patient-age>51</patient-age><outcomes/><country>United States</country><geo/></meta><original><ichicsr lang="en" xmlns="">
	<ichicsrmessageheader>
		<messagetype>psur</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>4254129_P31</messagenumb>
		<messagesenderidentifier>PFIZERINC</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20130125151552</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>1</safetyreportversion>
		<safetyreportid>US-PFIZER INC-2013032670</safetyreportid>
		<primarysourcecountry>US</primarysourcecountry>
		<occurcountry>US</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>2013-01-25</transmissiondate>
		<reporttype>1</reporttype>
		<serious code="2">No</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>2</seriousnesslifethreatening>
		<seriousnesshospitalization>2</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>2</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>2013-01-24</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>2013-01-24</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>2</fulfillexpeditecriteria>
		<companynumb>US-PFIZER INC-2013032670</companynumb>
		<medicallyconfirm>2</medicallyconfirm>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<reportercountry>US</reportercountry>
			<qualification code="5">Consumer or non-health professional</qualification>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>PFIZERINC</senderorganization>
			<senderfamilyname>Head Drug Safety Surveillance</senderfamilyname>
			<senderstreetaddress>150 East 42nd Street</senderstreetaddress>
			<sendercity>New York</sendercity>
			<senderstate>New York</senderstate>
			<senderpostcode>10017</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<sendertel>2127335544</sendertel>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receivertitle>Mr</receivertitle>
			<receivergivename>Roger</receivergivename>
			<receiverfamilyname>Goetsch</receiverfamilyname>
			<receiverstreetaddress>8201 Corporate Drive, Suite 540</receiverstreetaddress>
			<receivercity>Landover</receivercity>
			<receiverstate>MD</receiverstate>
			<receiverpostcode>20785</receiverpostcode>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>3019189580</receivertel>
			<receivertelextension>194</receivertelextension>
			<receivertelcountrycode>001</receivertelcountrycode>
			<receiverfax>3019183134</receiverfax>
			<receiverfaxcountrycode>001</receiverfaxcountrycode>
		</receiver>
		<patient>
			<patientinitial>PRIVACY</patientinitial>
			<patientonsetage>51</patientonsetage>
			<patientonsetageunit>801</patientonsetageunit>
			<patientweight>127</patientweight>
			<patientheight>165</patientheight>
			<patientsex code="2">Female</patientsex>
			<resultstestsprocedures>Unspecified blood work (Jan2013): normal.</resultstestsprocedures>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Blood pressure high</patientepisodename>
				<patientmedicalcontinue>1</patientmedicalcontinue>
				<patientmedicalcomment>taking unspecified medication</patientmedicalcomment>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>High cholesterol</patientepisodename>
				<patientmedicalcontinue>1</patientmedicalcontinue>
				<patientmedicalcomment>taking unspecified medication</patientmedicalcomment>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Diabetes</patientepisodename>
				<patientmedicalcontinue>1</patientmedicalcontinue>
				<patientmedicalcomment>taking unspecified medication</patientmedicalcomment>
			</medicalhistoryepisode>
			<reaction>
				<primarysourcereaction>toes had swelled</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Oedema lower limb</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Oedema peripheral</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>Lyrica</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationnumb>21-446</drugauthorizationnumb>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugauthorizationholder>Pfizer, Inc.</drugauthorizationholder>
				<drugstructuredosagenumb>225</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugdosagetext>225 mg, UNK</drugdosagetext>
				<drugdosageform normalized="capsule, hard">Capsule, hard</drugdosageform>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugstartdateformat>602</drugstartdateformat>
				<drugstartdate>2002</drugstartdate>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>PREGABALIN</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Oedema lower limb</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Oedema lower limb</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>Lyrica</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationnumb>21-446</drugauthorizationnumb>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugauthorizationholder>Pfizer, Inc.</drugauthorizationholder>
				<drugstructuredosagenumb>150</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>2</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>150 mg, 2x/day</drugdosagetext>
				<drugdosageform normalized="capsule, hard">Capsule, hard</drugdosageform>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>PREGABALIN</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Oedema lower limb</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Oedema lower limb</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<drugdosagetext>UNK</drugdosagetext>
				<activesubstance>
					<activesubstancename>IRON</activesubstancename>
				</activesubstance>
			</drug>
			<summary>
				<narrativeincludeclinical>This is a spontaneous report from a non clinical study program <Semaphore x="804590" class="Medicine" value="Lyrica" score="0.74" ID="275868">Lyrica </Semaphore>Answers by a contactable consumer.This <Semaphore x="1387834" class="Patient Age" value="51" score="1.00" ID=""><Semaphore x="5960701642276865" class="Patient Age" value="51" score="1.00" ID="">51 </Semaphore>year old </Semaphore><Semaphore x="1465257" class="Race" value="African American" score="1.00" ID="C16352">Black female </Semaphore>consumer started taking <Semaphore x="1082018" class="Medicine - pregabalin - Frequency" value="unknown" score="0.49" ID=""><Semaphore x="1082004" class="Medicine - pregabalin - Dose" value="225mg" score="0.74" ID=""><Semaphore x="1082033" class="Medicine" value="pregabalin" score="0.93" ID="239993">pregabalin </Semaphore>(<Semaphore x="804561" class="Medicine - Lyrica - Dose" value="225mg" score="0.49" ID=""><Semaphore x="804590" class="Medicine" value="Lyrica" score="0.74" ID="275868">LYRICA</Semaphore>) <Semaphore x="3455563182637057" class="Medicine - Lyrica - Dose" value="225mg" score="0.49" ID="">225mg </Semaphore></Semaphore></Semaphore>
     <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">oral </Semaphore></Semaphore>capsule unknown frequency for an unknown indication in 2002. Relevant medical history included <Semaphore x="3018504" class="MedDRA LLT" value="Hypertension" score="1.00" ID="10020772">high <Semaphore x="2801315" class="MedDRA LLT" value="Blood cholesterol" score="1.00" ID="10005422"><Semaphore x="2038093" class="Disease or Finding" value="Hypertension" score="1.00" ID="C3117">blood pressure</Semaphore>
       <Semaphore x="2038093" class="Disease or Finding" value="Hypertension" score="1.00" ID="C3117">, </Semaphore><Semaphore x="2036179" class="Disease or Finding" value="Hypercholesterolemia" score="1.00" ID="C37967">high </Semaphore></Semaphore></Semaphore>
    <Semaphore x="3018504" class="MedDRA LLT" value="Hypertension" score="1.00" ID="10020772">
     <Semaphore x="2801315" class="MedDRA LLT" value="Blood cholesterol" score="1.00" ID="10005422">
      <Semaphore x="2801167" class="MedDRA LLT" value="Blood cholesterol increased" score="1.00" ID="10005425">
       <Semaphore x="2036195" class="Disease or Finding" value="Hyperchromasia" score="1.00" ID="C82950">
        </Semaphore></Semaphore></Semaphore></Semaphore>
    <Semaphore x="2801315" class="MedDRA LLT" value="Blood cholesterol" score="1.00" ID="10005422">
     <Semaphore x="2801167" class="MedDRA LLT" value="Blood cholesterol increased" score="1.00" ID="10005425">
      <Semaphore x="2036195" class="Disease or Finding" value="Hyperchromasia" score="1.00" ID="C82950">
       <Semaphore x="2036179" class="Disease or Finding" value="Hypercholesterolemia" score="1.00" ID="C37967">cholesterol </Semaphore></Semaphore></Semaphore></Semaphore>and <Semaphore x="1845561" class="Disease or Finding" value="Diabetes Mellitus" score="1.00" ID="C2985">diabetes </Semaphore>and these conditions were ongoing at the time of events. Relevant concomitant medications included unspecified medication for <Semaphore x="2038093" class="Disease or Finding" value="Hypertension" score="1.00" ID="C3117"><Semaphore x="3018504" class="MedDRA LLT" value="Hypertension" score="1.00" ID="10020772">high <Semaphore x="2038093" class="Disease or Finding" value="Hypertension" score="1.00" ID="C3117">blood pressure</Semaphore></Semaphore>
     <Semaphore x="2038093" class="Disease or Finding" value="Hypertension" score="1.00" ID="C3117">, </Semaphore>unspecified medication for <Semaphore x="2036179" class="Disease or Finding" value="Hypercholesterolemia" score="1.00" ID="C37967">high </Semaphore></Semaphore>
    <Semaphore x="2801167" class="MedDRA LLT" value="Blood cholesterol increased" score="1.00" ID="10005425">
     <Semaphore x="2036195" class="Disease or Finding" value="Hyperchromasia" score="1.00" ID="C82950">
      <Semaphore x="2036179" class="Disease or Finding" value="Hypercholesterolemia" score="1.00" ID="C37967">cholesterol</Semaphore></Semaphore></Semaphore>, unspecified medication for <Semaphore x="1845561" class="Disease or Finding" value="Diabetes Mellitus" score="1.00" ID="C2985">diabetes </Semaphore>and <Semaphore x="744254" class="Medicine" value="Iron" score="0.49" ID="297813">iron </Semaphore>pill which she was taking at the time of events. On an unknown date she <Semaphore x="1863467" class="Procedure" value="Dose Reduced" score="1.00" ID="C49505">reduced the dose </Semaphore>of <Semaphore x="1082004" class="Medicine - pregabalin - Dose" value="225mg" score="0.74" ID=""><Semaphore x="1082033" class="Medicine" value="pregabalin" score="0.93" ID="239993">pregabalin </Semaphore>from <Semaphore x="4647171794141186" class="Medicine - pregabalin - Dose" value="225mg" score="0.74" ID="">225mg </Semaphore></Semaphore><Semaphore x="4647231923683331" class="Medicine - pregabalin - Frequency" value="unknown" score="0.49" ID="">unknown </Semaphore>frequency to 150mg two times a day for an unknown reason. On an unknown date while on <Semaphore x="1082033" class="Medicine" value="pregabalin" score="0.93" ID="239993">pregabalin </Semaphore><Semaphore x="4647171794141185" class="Medicine - pregabalin - Dose" value="150mg" score="0.49" ID="">150mg </Semaphore><Semaphore x="4647231923683330" class="Medicine - pregabalin - Frequency" value="two" score="0.49" ID="">two </Semaphore>times a day she mentioned that her <Semaphore x="2626975" class="AnatomicStructure" value="Toe" score="1.00" ID="C33788">toes </Semaphore>had <Semaphore x="2597501" class="Disease or Finding" value="Swelling" score="1.00" ID="C3399">swelled</Semaphore>. Relevant <Semaphore x="2091429" class="Disease or Finding" value="Laboratory Test Result" score="1.00" ID="C36292">lab </Semaphore>data included unspecified <Semaphore x="1608509" class="AnatomicStructure" value="Blood" score="1.00" ID="C12434">blood </Semaphore>work in Jan2013 <Semaphore x="1910095" class="Disease or Finding" value="Experimental Result" score="1.00" ID="C76125">results </Semaphore>of which were normal. At the time of report she was taking <Semaphore x="1082033" class="Medicine" value="pregabalin" score="0.93" ID="239993">pregabalin</Semaphore>. At the time of report clinical <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome </Semaphore>of the above mentioned event was unknown.No follow up attempts possible. No further information expected.</narrativeincludeclinical>
			</summary>
		</patient>
	</safetyreport>
</ichicsr></original></faers>